References - iarc

2 4 3 4 . Rosen PP, Groshen S, Saigo PE,
Kinne DW, Hellman S (1989). Pathological
prognostic factors in stage I (T1N0M0) and
stage II (T1N1M0) breast carcinoma: a
study of 644 patients with median followup
of 18 years. J Clin Oncol 7: 1239-1251.
2435. Rosen PP, Jozefczyk MA, Boram LH
(1985). Vascular tumors of the breast. IV.
The venous hemangioma. Am J Surg
Pathol 9: 659-665.
2436. Rosen PP, Kimmel M, Ernsberger D
(1988). Mammary angiosarcoma. The prognostic
significance of tumor differentiation.
Cancer 62: 2145-2151.
2437. Rosen PP, Kinne DW, Lesser M,
Hellman S (1986). Are prognostic factors
for local control of breast cancer treated
by primary radiotherapy significant for
patients treated by mastectomy? Cancer
57: 1415-1420.
2438. Rosen PP, Kosloff C, Lieberman PH,
Adair F, Braun DW Jr. (1978). Lobular carcinoma
in situ of the breast. Detailed
analysis of 99 patients with average follow-up
of 24 years. Am J Surg Pathol 2:
225-251.
2439. Rosen PP, Lesser ML, Arroyo CD,
Cranor M, Borgen P, Norton L (1995).
Immunohistochemical detection of
HER2/neu in patients with axillary lymph
node negative breast carcinoma. A study
of epidemiologic risk factors, histologic
features, and prognosis. Cancer 75: 1320-
1326.
2440. Rosen PP, Lesser ML, Arroyo CD,
Cranor M, Borgen P, Norton L (1995). p53 in
node-negative breast carcinoma: an
immunohistochemical study of epidemiologic
risk factors, histologic features, and
prognosis. J Clin Oncol 13: 821-830.
2441. Rosen PP, Lesser ML, Senie RT,
Kinne DW (1982). Epidemiology of breast
carcinoma III: relationship of family history
to tumor type. Cancer 50: 171-179.
2442. Rosen PP, Oberman HA (1993). Atlas
of Tumour Pathology. Tumour of the
Mammary Gland. Washington,D.C.
2443. Rosen PP, Ridolfi RL (1977). The perilobular
hemangioma. A benign microscopic
vascular lesion of the breast. Am J Clin
Pathol 68: 21-23.
2444. Rosen PP, Saigo PE, Braun DW Jr.,
Weathers E, Kinne DW (1981). Prognosis in
stage II (T1N1M0) breast cancer.Ann Surg
194: 576-584.
2445. Rosen PP, Saigo PE, Braun DW Jr.,
Weathers E, DePalo A (1981). Predictors of
recurrence in stage I (T1N0M0) breast carcinoma.
Ann Surg 193: 15-25.
2446. Rosen PP, Senie R, Schottenfeld D,
Ashikari R (1979). Noninvasive breast carcinoma:
frequency of unsuspected invasion
and implications for treatment. Ann
Surg 189: 377-382.
2447. Rosen PP, Wang T-Y (1980). Colloid
carcinoma of the breast. Analysis of 64
patients with long term followup. Am J Clin
Pathol 73: 304.
2448. Rosenberg CR, Pasternack BS, Shore
RE, Koenig KL, Toniolo PG (1994).
Premenopausal estradiol levels and the
risk of breast cancer: a new method of
controlling for day of the menstrual cycle.
Am J Epidemiol 140: 518-525.
2449. Rosenblatt KA, Thomas DB,
McTiernan A, Austin MA, Stalsberg H,
Stemhagen A, Thompson WD, Curnen MG,
Satariano W, Austin DF, et al. (1991).
Breast cancer in men: aspects of familial
aggregation. J Natl Cancer Inst 83: 849-
854.
2450. Rosenblatt KA, Weiss NS, Schwartz
SM (1989). Incidence of malignant fallopian
tube tumors. Gynecol Oncol 35: 236-239.
2451. Rosenfeld WD, Rose E, Vermund SH,
Schreiber K, Burk RD (1992). Follow-up
evaluation of cervicovaginal human papillomavirus
infection in adolescents. J
Pediatr 121: 307-311.
2452. Roses DF, Bell DA, Flotte TJ, Taylor R,
Ratech H, Dubin N (1982). Pathologic predictors
of recurrence in stage 1 (TINOMO)
breast cancer. Am J Clin Pathol 78: 817-
820.
2453. Rosner D, Lane WW, Penetrante R
(1991). Ductal carcinoma in situ with
microinvasion. A curable entity using surgery
alone without need for adjuvant therapy.
Cancer 67: 1498-1503.
2454. Ross JC, Eifel PJ, Cox RS, Kempson
RL, Hendrickson MR (1983). Primary mucinous
adenocarcinoma of the endometrium.
A clinicopathologic and histochemical
study. Am J Surg Pathol 7: 715-729.
2455. Ross LD (1984). Hilus cell tumour of
the ovary with an associated endometrial
carcinoma, presenting with male pattern
baldness and postmenopausal bleeding.
Case report. Br J Obstet Gynaecol 91: 1266-
1268.
2456. Ross MJ, Welch WR, Scully RE
(1989). Multilocular peritoneal inclusion
cysts (so-called cystic mesotheliomas).
Cancer 64: 1336-1346.
2457. Rossi G, Bonacorsi G, Longo L, Artusi
T, Rivasi F (2001). Primary high-grade
mucosa-associated lymphoid tissue-type
lymphoma of the cervix presenting as a
common endocervical polyp. Arch Pathol
Lab Med 125: 537-540.
2458. Rossing MA, Daling JR, Weiss NS,
Moore DE, Self SG (1994). Ovarian tumors
in a cohort of infertile women. N Engl J
Med 331: 771-776.
2459. Roth LM, Anderson MC, Govan AD,
Langley FA, Gowing NF, Woodcock AS
(1981). Sertoli-Leydig cell tumors: a clinicopathologic
study of 34 cases. Cancer 48:
187-197.
2460. Roth LM, Czernobilsky B (1985).
Ovarian Brenner tumors. II. Malignant.
Cancer 56: 592-601.
2461. Roth LM, Dallenbach-Hellweg G,
Czernobilsky B (1985). Ovarian Brenner
tumors. I. Metaplastic, proliferating, and of
low malignant potential. Cancer 56: 582-
591.
2462. Roth LM, Davis MM, Sutton GP
(1996). Steroid cell tumor of the broad liga -
ment arising in an accessory ovary. Arch
Pathol Lab Med 120: 405-409.
2463. Roth LM, Deaton RL, Sternberg WH
(1979). Massive ovarian edema. A clinicopathologic
study of five cases including
ultrastructural observations and review of
the literature. Am J Surg Pathol 3: 11-21.
2464. Roth LM, Gersell DJ, Ulbright TM
(1993). Ovarian Brenner tumors and transi -
tional cell carcinoma: recent developments.
Int J Gynecol Pathol 12: 128-133.
2465. Roth LM, Gersell DJ, Ulbright TM
(1996). Transitional cell carcinoma and
other transitional cell tumors of the ovary.
Anat Pathol 1: 179-191.
2466. Roth LM, Liban E, Czernobilsky B
(1982). Ovarian endometrioid tumors mimicking
Sertoli and Sertoli-Leydig cell
tumors: Sertoliform variant of endometrioid
carcinoma. Cancer 50: 1322-1331.
2467. Roth LM, Look KY (2000). Inverted follicular
keratosis of the vulvar skin: a lesion
that can be confused with squamous cell
carcinoma. Int J Gynecol Pathol 19: 369-
373.
2468. Roth LM, Nicholas TR, Ehrlich CE
(1979). Juvenile granulosa cell tumor: a
clinicopathologic study of three cases with
ultrastructural observations. Cancer 4 4 :
2194-2205.
2469. Roth LM, Reed RJ (1999). Dissecting
leiomyomas of the uterus other than
cotyledonoid dissecting leiomyomas: a
report of eight cases. Am J Surg Pathol 23:
1032-1039.
2470. Roth LM, Reed RJ, Sternberg WH
(1996). Cotyledonoid dissecting leiomyoma
of the uterus. The Sternberg tumor. Am J
Surg Pathol 20: 1455-1461.
2471. Roth LM, Slayton RE, Brady LW,
Blessing JA, Johnson G (1985). Retiform
differentiation in ovarian Sertoli-Leydig
cell tumors. A clinicopathologic study of
six cases from a Gynecologic Oncology
Group study. Cancer 55: 1093-1098.
2472. Roth LM, Sternberg WH (1973).
Ovarian stromal tumors containing Leydig
cells. II. Pure Leydig cell tumor, non-hilar
type. Cancer 32: 952-960.
2473. Rothbard MJ, Markham EH (1974).
Leiomyosarcoma of the cervix: report of a
case. Am J Obstet Gynecol 120: 853-854.
2474. Royar J, Becher H, Chang-Claude J
(2001). Low-dose oral contraceptives: protective
effect on ovarian cancer risk. Int J
Cancer 95: 370-374.
2475. Roylance R, Gorman P, Hanby A,
Tomlinson I (2002). Allelic imbalance
analysis of chromosome 16q shows that
grade I and grade III invasive ductal breast
cancers follow different genetic pathways.
J Pathol 196: 32-36.
2476. Roylance R, Gorman P, Harris W,
Liebmann R, Barnes D, Hanby A, Sheer D
(1999). Comparative genomic hybridization
of breast tumors stratified by histological
grade reveals new insights into the biological
progression of breast cancer. Cancer
Res 59: 1433-1436.
2477. Rozan S, Vincent-Salomon A, Zafrani
B, Validire P, de Cremoux P, Bernoux A,
Nieruchalski M, Fourquet A, Clough K,
Dieras V, Pouillart P, Sastre-Garau X
(1998). No significant predictive value of cerbB-2
or p53 expression regarding sensitivity
to primary chemotherapy or radiotherapy
in breast cancer. Int J Cancer 79:
27-33.
2478. Rubens JR, Lewandrowski KB,
Kopans DB, Koerner FC, Hall DA, McCarthy
KA (1990). Medullary carcinoma of the
breast. Overdiagnosis of a prognostically
favorable neoplasm. Arch Surg 125: 601-
604.
2479. Rubin SC, Benjamin I, Behbakht K,
Takahashi H, Morgan MA, LiVolsi VA,
Berchuck A, Muto MG, Garber JE, Weber
BL, Lynch HT, Boyd J (1996). Clinical and
pathological features of ovarian cancer in
women with germ-line mutations of
BRCA1. N Engl J Med 335: 1413-1416.
2480. Rubin SC, Young J, Mikuta JJ (1985).
Squamous carcinoma of the vagina: treatment,
complications, and long-term followup.
Gynecol Oncol 20: 346-353.
2481. Rubio IT, Korourian S, Brown H,
Cowan C, Klimberg VS (1998). Carcinoid
tumor metastatic to the breast. Arch Surg
133: 1117-1119.
2482. Rudan I, Rudan N, Skoric T, Sarcevic
B (1996). Fibromatosis of male breast. Acta
Med Croatica 50: 157-159.
2483. Rudas M, Neumayer R, Gnant MF,
Mittelbock M, Jakesz R, Reiner A (1997).
p53 protein expression, cell proliferation
and steroid hormone receptors in ductal
and lobular in situ carcinomas of the
breast. Eur J Cancer 33: 39-44.
2484. Rudas M, Schmidinger M, Wenzel C,
Okamoto I, Budinsky A, Fazeny B, Marosi C
(2000). Karyotypic findings in two cases of
male breast cancer. Cancer Genet
Cytogenet 121: 190-193.
2485. Ruffolo EF, Koerner FC, Maluf HM
(1997). Metaplastic carcinoma of the
breast with melanocytic differentiation.
Mod Pathol 10: 592-596.
2486. Ruggieri AM, Brody JM, Curhan RP
(1996). Vaginal leiomyoma. A case report
with imaging findings. J Reprod Med 41:
875-877.
2487. Runnebaum IB, Wang-Gohrke S,
Vesprini D, Kreienberg R, Lynch H, Moslehi
R, Ghadirian P, Weber B, Godwin AK, Risch
H, Garber J, Lerman C, Olopade OI, Foulkes
WD, Karlan B, Warner E, Rosen B,
Rebbeck T, Tonin P, Dube MP, Kieback DG,
Narod SA (2001). Progesterone receptor
variant increases ovarian cancer risk in
BRCA1 and BRCA2 mutation carriers who
were never exposed to oral contraceptives.
Pharmacogenetics 11: 635-638.
2488. Rush DS, Tan J, Baergen RN, Soslow
RA (2001). h-Caldesmon, a novel smooth
muscle-specific antibody, distinguishes
between cellular leiomyoma and endometrial
stromal sarcoma. Am J Surg Pathol 25:
253-258.
2489. Russell P (1979). The pathological
assessment of ovarian neoplasms. I:
Introduction to the common 'epithelial'
tumours and analysis of benign 'epithelial'
tumours. Pathology 11: 5-26.
2490. Russell P (1979). The pathological
assessment of ovarian neoplasms. II: The
proliferating 'epithelial' tumours.
Pathology 11: 251-282.
2491. Russell P, Merkur H (1979).
Proliferating ovarian "epithelial" tumours: a
clinico-pathological analysis of 144 cases.
Aust N Z J Obstet Gynaecol 19: 45-51.
2492. Russell P, Wills EJ, Watson G, Lee J,
Geraghty T (1995). Monomorphic (basal
cell) salivary adenoma of ovary: report of a
case. Ultrastruct Pathol 19: 431-438.
2493. Russell PA, Pharoah PD, De Foy K,
Ramus SJ, Symmonds I, Wilson A, Scott I,
Ponder BA, Gayther SA (2000). Frequent
loss of BRCA1 mRNA and protein expression
in sporadic ovarian cancers. Int J
Cancer 87: 317-321.
2494. Russo L, Woolmough E, Heatley MK
(2000). Structural and cell surface antigen
expression in the rete ovarii and
epoophoron differs from that in the
Fallopian tube and in endometriosis.
Histopathology 37: 64-69.
2495. Rutgers JL, Scully RE (1988). Cysts
(cystadenomas) and tumors of the rete
ovarii. Int J Gynecol Pathol 7: 330-342.
2496. Rutgers JL, Scully RE (1988). Ovarian
mixed-epithelial papillary cystadenomas of
borderline malignancy of mullerian type. A
clinicopathologic analysis. Cancer 61: 546-
554.
2497. Rutgers JL, Scully RE (1988). Ovarian
mullerian mucinous papillary cystadenomas
of borderline malignancy. A clinicopathologic
analysis. Cancer 61: 340-348.
2498. Rutgers JL, Scully RE (1991). The
androgen insensitivity syndrome (testicular
feminization): a clinicopathologic study
of 43 cases. Int J Gynecol Pathol 10: 126-
144.
References 411